Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003340711 | SCV004047372 | likely pathogenic | Glycogen storage disease, type VI | criteria provided, single submitter | clinical testing | The c.916C>T (p.Gln306Ter) stop gained variant in PYGL gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.916C>T variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. The nucleotide change c.916C>T in PYGL is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. |